- Home
- » Tags
- » Oncolytic herpes virus
Top View
- Oncolytic Activity of HF10 in Head and Neck Squamous Cell Carcinomas
- Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy Frederick J
- Antitumor Efficacy of Oncolytic Herpes Simplex Virus Adsorbed Onto
- IMLYGIC (Talimogene Laherparepvec) RATIONALE for INCLUSION IN
- Oncolytic Herpes Simplex Virus and Immunotherapy Wenqing Ma, Hongbin He* and Hongmei Wang*
- (T-VEC), a First-In-Class Intratumoral Oncolytic Viral Therapy Hasan Rehman, Ann W
- Combined Oncolytic Virotherapy with Herpes Simplex Virus for Oral Squamous Cell Carcinoma FUMI OGAWA, HIROO TAKAOKA, SOICHI IWAI, KEIKO AOTA and YOSHIAKI YURA
- The Effect of the Tumor Microenvironment on Oncolytic Virus Therapy for Glioblastoma
- The Emerging Role of Oncolytic Virus Therapy Against Cancer
- Armed Oncolytic Viruses a Kick-Start for Anti-Tumor Immunity
- Perspectives on Immunotherapy Via Oncolytic Viruses Alberto Reale, Adriana Vitiello, Valeria Conciatori, Cristina Parolin, Arianna Calistri and Giorgio Palù*
- Systemic Versus Local Responses in Melanoma Patients Treated with Talimogene Laherparepvec from a Multi-Institutional Phase II Study Howard L